Sooma Medical enters into procurement agreement with VSSHP The Hospital District of Southwest Finland (VSSHP) has entered into a procurement agreement with Sooma Oy for the procurement of… Read more
Sooma Closes an Investment Round of Over 1.2 Million EUR Sooma Closes an Investment Round of Over 1.2 Million EUR Sooma Oy, a Finnish medical device company developing non-invasive brain… Read more
Sooma Treatment Outcomes (2019) During the last 20 years, the efficacy and safety of transcranial direct current stimulation (tDCS) in various indications have been… Read more
MD & Associate Professor Rechdi Ahdab The following testimonial was given by Medical Doctor and Associate Professor of Medicine, Rechdi Ahdab. Dr. Ahdab has been using tDCS… Read more
Sooma Medical Awarded US Patent for Advanced Stimulation Electrode Official Press Release Helsinki, Finland, January 11, 2019 (Newswire.com) – Sooma Medical announces receipt… Read more
MD & Senior Psychiatrist Margus Lõokene The following testimonial was given by Medical Doctor and Senior Psychiatrist Margus Lõokene. Dr. Lõokene has been working as a senior psychiatrist… Read more
Sooma Treatment Outcomes (2018) Treatment Outcomes for Sooma Depression Therapy During the last few years, transcranial direct current stimulation (tDCS) has become a… Read more
Sooma accepted into the Young Innovative Companies program of Business Finland We are happy to announce that Sooma Oy has been accepted into the Young Innovative Companies (YIC) program of Business… Read more
Sooma depression treatment receives HSA approval in Singapore Helsinki, Finland – December 12, 2017 Sooma Oy is proud to announce that it has received Singapore’s Health Sciences Authority (HSA)… Read more
Trial of Escitalopram versus tDCS for Depression Many of us who follow the science of electrical stimulation had high expectations when, in June, New England Journal of… Read more
